Cambridge Investment Research Advisors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-16,711
| Closed | -$38K | – | 3543 |
|
|
2024
Q2 | $38K | Sell |
16,711
-100
| -0.6% | -$227 | ﹤0.01% | 3239 |
|
|
2024
Q1 | $73K | Buy |
16,811
+5,000
| +42% | +$21.7K | ﹤0.01% | 3183 |
|
|
2023
Q4 | $36K | Buy |
+11,811
| New | +$36K | ﹤0.01% | 3117 |
|
|
2022
Q1 | – | Sell |
-12,667
| Closed | -$129K | – | 3341 |
|
|
2021
Q4 | $129K | Sell |
12,667
-4,250
| -25% | -$43.3K | ﹤0.01% | 2997 |
|
|
2021
Q3 | $227K | Buy |
16,917
+3,812
| +29% | +$51.2K | ﹤0.01% | 2706 |
|
|
2021
Q2 | $288K | Buy |
13,105
+4,753
| +57% | +$104K | ﹤0.01% | 2501 |
|
|
2021
Q1 | $201K | Buy |
+8,352
| New | +$201K | ﹤0.01% | 2624 |
|